Medicus Pharma Ltd.
MDCX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -59.89M | -54.45M | -50.51M | -35.75M | -17.09M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 0.00 | 111.70K | 111.70K | 111.70K | 111.70K |
| Total Other Non-Cash Items | 22.32M | 20.81M | 19.82M | 16.07M | 590.30K |
| Change in Net Operating Assets | 1.02M | -1.52M | 569.80K | 206.10K | 688.40K |
| Cash from Operations | -29.32M | -27.81M | -22.78M | -19.36M | -15.70M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.62M | -4.62M | -4.62M | -4.62M | -- |
| Cash from Investing | -4.62M | -4.62M | -4.62M | -4.62M | -- |
| Total Debt Issued | 29.37M | 11.87M | 11.87M | 11.87M | 4.50M |
| Total Debt Repaid | -12.92M | -10.58M | -7.39M | -5.64M | -- |
| Issuance of Common Stock | 33.99M | 34.48M | 28.25M | 21.83M | 12.82M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.05M | -765.20K | -790.20K | -721.10K | -352.40K |
| Cash from Financing | 49.38M | 35.01M | 31.94M | 27.34M | 16.96M |
| Foreign Exchange rate Adjustments | 81.60K | -198.00K | -2.90K | -1.70K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.52M | 2.38M | 4.54M | 3.36M | 1.26M |